InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Milestone Pharmaceuticals Inc.

MIST Clue Score21
Quebec, Canada Fiscal year ends December CIK 0001408443
$0.77 +7.43% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.77 −86.92% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 9 May 2019. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2018Operating income−23.8Net income−23.2Fiscal year 2019Operating income−57.9Net income−55.2Fiscal year 2020Operating income−50.7Net income−50.0EPS, diluted−1.70Fiscal year 2021Operating income−43.1Net income−42.9EPS, diluted−1.02Fiscal year 2022Operating income−59.6Net income−58.4EPS, diluted−1.38Fiscal year 2023Operating income−61.1Net income−59.7EPS, diluted−1.39Fiscal year 2024Operating income−42.1Net income−41.5EPS, diluted−0.67Fiscal year 2025Operating income−62.1Net income−63.1EPS, diluted−0.75
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating income −23.8 −57.9 −50.7 −43.1 −59.6 −61.1 −42.1 −62.1
Net income −23.2 −55.2 −50.0 −42.9 −58.4 −59.7 −41.5 −63.1
Growth
EPS, diluted n/a n/a −1.70 −1.02 −1.38 −1.39 −0.67 −0.75
Growth

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2018Operating cash flow−21.0Capital expenditure−0.0Free cash flow−21.1Fiscal year 2019Operating cash flow−51.2Capital expenditure−0.4Free cash flow−51.6Fiscal year 2020Operating cash flow−50.7Fiscal year 2021Operating cash flow−33.2Fiscal year 2022Operating cash flow−52.5Capital expenditure−0.3Free cash flow−52.7Fiscal year 2023Operating cash flow−46.4Capital expenditure−0.1Free cash flow−46.5Fiscal year 2024Operating cash flow−28.8Capital expenditure−0.0Free cash flow−28.9Fiscal year 2025Operating cash flow−49.0Capital expenditure−0.3Free cash flow−49.3
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Operating cash flow −21.0 −51.2 −50.7 −33.2 −52.5 −46.4 −28.8 −49.0
Capital expenditure −0.0 −0.4 n/a n/a −0.3 −0.1 −0.0 −0.3
Free cash flow −21.1 −51.6 n/a n/a −52.7 −46.5 −28.9 −49.3
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
CashTotal debt
Fiscal year 2018Cash85.9Shareholders’ equity83.5Fiscal year 2019Cash119.8Total debt0.0Net cash (debt)119.8Shareholders’ equity114.9Debt to equity0.00Fiscal year 2020Cash72.3Shareholders’ equity143.1Fiscal year 2021Cash114.1Shareholders’ equity112.6Fiscal year 2022Cash7.6Shareholders’ equity66.3Fiscal year 2023Cash13.8Total debt49.8Net cash (debt)−36.0Shareholders’ equity16.8Debt to equity2.97Fiscal year 2024Cash25.3Total debt53.4Net cash (debt)−28.0Shareholders’ equity13.1Debt to equity4.06Fiscal year 2025Cash73.0Total debt57.2Net cash (debt)15.9Shareholders’ equity41.8Debt to equity1.37
FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Cash 85.9 119.8 72.3 114.1 7.6 13.8 25.3 73.0
Total debt n/a 0.0 n/a n/a n/a 49.8 53.4 57.2
Net cash (debt) n/a 119.8 n/a n/a n/a −36.0 −28.0 15.9
Shareholders’ equity 83.5 114.9 143.1 112.6 66.3 16.8 13.1 41.8
Debt to equity n/a 0.00 n/a n/a n/a 2.97 4.06 1.37

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2018 31 Dec 2018 FY2019 31 Dec 2019 FY2020 31 Dec 2020 FY2021 31 Dec 2021 FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Returns
−27.8% −48.1% −34.9% −38.1% −88.0% −355.9% −315.8% −151.0%
−26.3% −44.7% −33.3% −35.8% −78.4% −79.3% −55.0% −55.5%
Balance and payout
n/a 0.00 n/a n/a n/a 2.97 4.06 1.37
5.1% 6.9% 4.6% 6.0% 10.9% 77.7% 82.6% 63.2%